Journal Home
Search for

Volume 40, Issue 7, Pages 595-599 (October 2009)


View previous. 15 of 24 View next.

Expression of Prostate Apoptosis Response (Par-4) Is Associated with Progesterone Receptor in Breast Cancer

Pablo Zapata-Benavidesa, José L. Méndez-Vázqueza, Talina R. González-Rochab, Diana E. Zamora-Avilaa, Moises A. Franco-Molinaa, Raúl Garza-Garzab, Cristina Rodriguez-PadillaaCorresponding Author Informationemail addressemail address

Received 24 October 2008; accepted 31 July 2009.

Background

The prostate apoptosis response (Par-4) gene encodes a proapoptotic protein that selectively induces apoptosis in cancer cells after diverse apoptotic stimuli. Par-4 expression and its association with other biomarkers have not been reported in breast cancer. The purpose of this study was to determine Par-4 expression in breast cancer samples and its association with other biomarkers and clinical factors (T-stage, age, nodal status).

Methods

Paraffin-embedded section samples of breast cancer were evaluated by immunohistochemical analysis to determine Par-4, estrogen receptor (ER), progesterone receptor (PgR), c-erbB2, Ki67, p53 and bcl-2 expression. The correlation between Par-4 and the other biomarkers and clinical factors was determined by multivariate analysis.

Results

Thirty five percent (n=21) of samples were PAR-4 positive and 64.4% (n=38) were negative. The hormonal status was 64% ER positive (n=38), 35% ER-negative (n=21) and 40.7% PgR positive (n=24), 59.3% PgR negative (n=35). The majority (90%) of the samples presented clear cytoplasmic localization and a small portion (10%) was cytoplasmic and nuclear. Univariate analysis indicates that the Par-4 expression has a significant inverse association (p=0.04) only with expression of PgR and not with the other variables analyzed. Normal breast tissue analyzed was negative for Par-4 immunostaining.

Conclusions

Our results suggest that, in breast cancer, Par-4 plays a similar tumor suppressor gene role as reported in endometrial carcinoma

(ARCMED-D-08-00482)

a Departamento de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, México

b Laboratorio de Anatomía Patológica, Hospital Christus Muguerza, Monterrey, Nuevo León, México

Corresponding Author InformationAddress reprint requests to: Cristina Rodriguez-Padilla, Pedro de Alba S/N, San Nicolás de los Garza, 66450 Nuevo León, México; FAX: (+52) (81) 8352-4212

PII: S0188-4409(09)00149-0

doi:10.1016/j.arcmed.2009.08.007


View previous. 15 of 24 View next.